Showing results (21-30 of 578) with videos related to
Sort By:
Pageof 58
European Archives of Psychiatry and Clinical Neuroscience|August 4, 2005
Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual reviewHans-Jürgen Möller, Heinz Grunze, Karl BroichEuropean Archives of Psychiatry and Clinical Neuroscience|October 21, 2010
Anticholinergic drug use and risk for dementia: target for dementia preventionFrank Jessen, Hanna Kaduszkiewicz, Moritz Daerr, et al.Dialogues in Clinical Neuroscience|July 10, 2009
Biological markers for early detection and pharmacological treatment of Alzheimer's diseaseHarald Hampel, Karl Broich, Yvonne Hoessler, et al.Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 12, 2024
[Establishment of the new "Health Data Lab" to provide data for science]Melanie Ludwig, Katharina Schneider, Steffen Heß, et al.Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 26, 2016
[Improving drug licensing for children and adolescents : Position paper from the More Medicines for Minors Symposion 8 June 2015 in Bonn]Claudia Riedel, Birka Lehmann, Karl Broich, et al.Journal of Neuroscience Methods|May 14, 2016
Sampling rate, signal bandwidth and related pitfalls in EEG analysisMarco Weiergräber, Anna Papazoglou, Karl Broich, et al.The Journal of Prevention of Alzheimer'S Disease|February 26, 2025
Patient eligibility for amyloid-targeting immunotherapies in Alzheimer's diseaseJurij Rosen, Frank JessenDer Nervenarzt|April 18, 2020
[Early detection of Alzheimer's disease and dementia prediction in patients with mild cognitive impairment : Summary of current recommendations]Ayda Rostamzadeh, Frank JessenFortschritte Der Neurologie-Psychiatrie|May 18, 2021
[Predictive Diagnosis of Alzheimer's Dementia]Ayda Rostamzadeh, Frank JessenFortschritte Der Neurologie-Psychiatrie|April 6, 2018
[ICD-11: Neurocognitive Disorders]Frank Jessen, Lutz FrölichPageof 58